Table: Sapporo Clinical Lab -2021/22 group results

Sapporo Clinical Laboratory

13/05/2022 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           19.11           17.50          19.36         9.45    
               (+9.2 pct)      (-0.9 pct)     (+1.3 pct)    (-1.2 pct) 
  Operating        1.54            1.14           1.17       485 mln   
               (+34.6 pct)     (+20.9 pct)    (-24.2 pct)  (-37.6 pct) 
  Recurring        1.61            1.19           1.11       476 mln   
               (+35.1 pct)     (+20.9 pct)    (-30.8 pct)  (-41.9 pct) 
  Net
  Net              1.04          793 mln        714 mln      301 mln   
               (+31.4 pct)     (+50.3 pct)    (-31.5 pct)  (-34.2 pct) 
  EPS          306.16 yen      231.85 yen     213.01 yen    89.88 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T